Salute e Benessere

Novartis radioligand therapy Lutathera® demonstrated statistically significant…

Phase III NETTER-2 trial met primary endpoint of improvement in progression-free survival (PFS) and key secondary endpoint of objective response rate (ORR) in patients with Grade 2 and 3 advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) who received first line treatment with Lutathera ®in combination with long-acting octreotide, versus high-dose long-acting octreotide alone 1,2 Lutathera is the first radioligand therapy (RLT) to demonstrate clinically...
Nasdaq GlobeNewswire
25/09/2023

Novartis confirms Sandoz Spin-off for October 4, 2023

Sandoz shares (SDZ) to be listed and traded on SIX Swiss Exchange; ADRs to be traded on OTCQX ®, first trading day October 4, 2023Sandoz to be included in key Swiss market indicesInvestment grade credit rating for Sandoz confirmed: Moody's, Baa2; S&P, BBBDebt financing of USD 3.75 billion (in various currencies) secured for Sandoz, supported by USD 1.25 billion revolving credit facilitySpin-off to be completed by way of a 1:5 distribution of Sandoz shares to...
Nasdaq GlobeNewswire
25/09/2023

LEQEMBI® Intravenous Infusion (Lecanemab) Approved for the Treatment of…

TOKYO and CAMBRIDGE, Mass., Sept.25, 2023(GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody LEQEMBI ®Intravenous Infusion (200 mg, 500mg, lecanemab) has been approved in Japan as a treatment for slowing progression of mild cognitive...
Nasdaq GlobeNewswire
25/09/2023

Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a…

Saint Herblain(France), September 25 , 2023– Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32 million contract with the United States (U.S.) Department of Defense (DoD) for the supply of its Japanese encephalitis (JE) vaccine, IXIARO ®. Under this new one-year contract, the DoD will buy a minimum of $32 million worth of IXIARO ®vaccines and has the possibility to purchase additional doses during the...
Nasdaq GlobeNewswire
25/09/2023

Insulin Pump Market Size is Expected to Reach USD 12.18 Billion by 2028, With a…

The market trends report is curated with an aim to help businesses understand the overall dynamics of this industry. The growth drivers, challenges, opportunities, and restraints are thoroughly elaborated in this report. It offers market size forecast along with projected market share over the stipulated timeline. This report further bifurcates the industry on the basis of various segments. These segments are analysed with an aim to determine the exact size and scope of this business vertical…
PR Newswire
25/09/2023

Pharmacovigilance Market Analysis 2023-2027: Market Size, Growth Rate And Major…

Rising Healthcare Expenditure Fuels Growth Rising Healthcare Expenditure Fuels Growth The driving force behind this robust pharmacovigilance market growth is the escalation in healthcare expenditure. Increased funding allows healthcare systems to invest in cutting-edge technologies, data analytics, and expert teams dedicated to efficiently identifying and assessing adverse drug reactions. For instance, according to the Centers for Medicare & Medicaid Services, the average National...
PR Newswire
22/09/2023

Medical Equipment Maintenance Market worth $80.7 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69695102 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69695102 Browse in-depth TOC on "Medical Equipment Maintenance Market"241 - Tables53 - Figures 319 - Pages Medical Equipment Maintenance Market Scope: The diagnostic imaging equipment segment is to register a significant growth rate over the forecast period of 2023-2028...
PR Newswire
22/09/2023

Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for…

"We are so pleased to achieve this positive step towards providing the first long-term prophylactic treatment option to prevent attacks in this vulnerable population," said Didier Relin, Head of International Regulatory at Takeda. "We know that HAE can be a complex, debilitating condition, and we are committed to being a champion for all individuals living with HAE." "We are so pleased to achieve this positive step towards providing the first long-term prophylactic…
PR Newswire
22/09/2023

Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal…

At the 2023 ASCO Annual Meeting Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) shared exciting results from its important study, called BRACELET-1, with results that caught the eye of RBC Capital. The oral presentation shared at the event described how they've been testing a treatment for advanced breast cancer, and it's looking very promising. At the 2023 ASCO Annual MeetingOncolytics Biotech Inc.(NASDAQ: ONCY) (TSX: ONC) shared exciting results from its important study, called...
PR Newswire
22/09/2023

Single-Use Bioprocessing Market size worth USD 15.1 Billion, Globally, by 2030…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=24194 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=24194 Browse in-depth TOCon" Single-Use Bioprocessing Market " 202 - Pages 126 – Tables 37 – Figures Global Single-Use Bioprocessing Market: Drivers, Opportunities, Outlook, and Key Players The global Single-Use Bioprocessing Market is poised for substantial growth, driven by a confluence of...
PR Newswire
22/09/2023

Biomerics Announces Completion of 100,000 sq. ft. Expansion of Brooklyn Park…

The 100,000-square-foot expansion includes 20,000 square feet dedicated to expanding micro metals laser processing; 24,000 square feet for complex extrusion processing, with 2,000 square feet of that certified as ISO class 8 cleanroom space; and 10,000 square feet for advanced catheter processing. The expansion also provides additional areas for employee training and office space. The 100,000-square-foot expansion includes 20,000 square feet dedicated to expanding micro metals laser…
PR Newswire
22/09/2023

Mithra présentera ses résultats financiers du premier semestre 2023 à ses…

Mithra présentera ses résultats financiers du premier semestre 2023 à ses investisseurs lors d'une conférence web le 26 septembre à 14 h 00 CETLiège, Belgique, 22 septembre 2023 – 13 h 30 CET– Mithra (Euronext Brussels : MITRA), société spécialisée dans la santé féminine, annonce aujourd'hui qu'elle présentera ses résultats financiers semestriels pour la période de six mois terminée le 30 juin 2023, à l'occasion d'une conférence web.Cette conférence se déroulera en...
Nasdaq GlobeNewswire
22/09/2023

Unlocking the Future of Drug Discovery with Artificial Intelligence

Stand Out Facts Stand Out Facts Now is the Time to Act The AI in the Drug Discovery sector is witnessing unprecedented growth, underscored by a significant increase in venture capital funding for AI-driven biotech startups, reaching approximately$1.9 billionin 2020 alone. Although this data is from 2020, it is a testament to the sector's robust expansion. In 2022, the AI startup investment landscape continued to thrive, with 27 deals totaling about$1.94 billion(€1.8 billion)...
PR Newswire
22/09/2023

Lipogems® Announces 140 independent Peer Reviewed Publications with 5 years of…

Lipogems has been used in more than 60,000 procedures worldwide and is currently FDA cleared for use in the US for general applications in orthopaedics, arthroscopy, and nine other specialties since 2014. Lipogems partners with leading institutions to keep their patients in their care continuum, offering physicians a compliant option for both surgical and non-operative applications. Lipogems has been used in more than 60,000 procedures worldwide and is currently FDA cleared for use in the US...
PR Newswire
22/09/2023

Combining best-in-class AI-powered Technologies for Musculoskeletal (MSK)…

Globally, musculoskeletal conditions affect a larger population than circulatory or respiratory disorders. Despite this, diagnostic methods often remain rooted in outdated practices, relying on manual interpretation of X-rays and MRI images. These subjective and time-intensive techniques lack standardisation and depend on practitioner expertise. Globally, musculoskeletal conditions affect a larger population than circulatory or respiratory disorders. Despite this, diagnostic methods often...
PR Newswire
22/09/2023

134th Canton Fair's Launched Promotion Activities in Italy, Hungary, and…

In addition, Xu and his team paid a visit to Coop Italia, a long-standing Italian buyer of the Canton Fair, and forged a new partnership with UNSIC Piemonte Branch in Italy. Xu Bing emphasized the Fair's commitment to playing an increasingly active role in fostering trade cooperation between China and nations across the globe. The Canton Fair is dedicated to facilitating business information exchange and fostering marketing project cooperation, to provide more convenient services for members of…
PR Newswire
22/09/2023

ZINZINO AB (PUBL): Zinzino announces Mexico as next step in its global expansion

Profitable growth has always been a vital business strategy for the e-commerce-based, health tech company. Zinzino will now maintain its high growth ambitions with a goal to reach 1 million customers by the year 2025 and 20 million by 2035. With the launch in Mexico, Zinzino is operating in more than 100 markets while continuing to focus on further global expansion. Profitable growth has always been a vital business strategy for the e-commerce-based, health tech company. Zinzino will now...
PR Newswire
22/09/2023

Press Release: Availability of the Q3 2023 Memorandum for modelling purposes

Availability of the Q3 2023 Memorandum for modelling purposesParis, France – September 22 , 2023. Sanofi announced today that its Q3 2023 Memorandum for modelling purposes is available on the "Investors" page of the company's website: https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/q3-results-2023 As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results. This document...
Nasdaq GlobeNewswire
22/09/2023

Chronic Lower Back Pain Market to Showcase Tremendous Growth by 2032, Predicts…

Key Takeaways from the Chronic Lower Back Pain Market Report Key Takeaways from the Chronic Lower Back Pain Market Report Discover which therapies are expected to grab the major chronic lower back pain market share @Chronic Lower Back Pain Market Report Chronic Lower Back Pain Overview Chronic lower back pain is a prevalent and debilitating medical condition that affects millions of individuals worldwide. Unlike acute back pain, which typically resolves within a few weeks,...
PR Newswire
21/09/2023

PHAXIAM Provides Business and Financial Update For the First Half of 2023

PHAXIAM Provides Business and Financial Update For the First Half of 2023 Conference call and webcast (English) on Monday, September 25, 2023 at 8:30am ET / 2:30pm CESTFormation of PHAXIAM Therapeutics effective as of June 23, 2023 , to create a global leaderinphage therapiesfor high-value indicationsAmbitious strategyto develop value-creatingclinical and regulatory plan in severe and resistantbacterial infectionsPlan to launch new and first...
Nasdaq GlobeNewswire
21/09/2023

Breakthrough Properties to Develop New European Headquarters for Neogene…

AMSTERDAM, Sept. 21, 2023 /PRNewswire/ -- Breakthrough Properties, a premier global life sciences real estate developer, announced that it has reached an agreement with Neogene Therapeutics to develop its new European headquarters within the campus of the Amsterdam University Medical Center (Amsterdam UMC), one of Europe's leading medical institutions. AMSTERDAM,Sept. 21, 2023/PRNewswire/ --Breakthrough Properties, a premier global life sciences real estate developer, announced that it...
PR Newswire
21/09/2023

The Wearable Injectors Market is anticipated to grow at a CAGR of 9.01%, during…

Wearable injectors are compact, portable self-injection devices specifically designed to enable subcutaneous delivery of substantial amounts of drugs, producing a sustained therapeutic effect. These innovative systems offer numerous dosing options (basal, bolus or continuous), improving patient adherence and efficacy of treatments. Wearable injectors are compact, portable self-injection devices specifically designed to enable subcutaneous delivery of substantial amounts of drugs, producing a...
PR Newswire
21/09/2023

Information on the total number of voting rights (denominator)

Information on the total number of voting rights (denominator)Liege, Belgium, 21 September 2023 – 5:45pm CEST– Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces that, following the first, second and first part of the third drawdown by the Company under the loan facility concluded by the Company with certain funds managed by Highbridge Capital Management, LLC (“Highbridge“) and funds managed by Whitebox Advisors, LLC (“Whitebox“,...
Nasdaq GlobeNewswire
21/09/2023

Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at…

Mithrato Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CESTLiege, Belgium ,September 21,2023– 5:45 pm CEST– Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces it will host a conference call to present its financial results for the six-month period ended on June 30, 2023.The call will take place on September 26 at 14:00 CEST and will be held in English. Participants can attend/register...
Nasdaq GlobeNewswire
21/09/2023
Altri  Comunicati